UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.729

Sortiert nach

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation

OncoTargets and therapy, 2022-11, Vol.15, p.1369-1374

2022

Volltextzugriff (PDF)

Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018

Annals of oncology, 2018-10, Vol.29, p.viii491-viii491

2018

Volltextzugriff (PDF)

703 S. epidermidis increases contact sensitization inflammation through the S1P receptor 2

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S121-S121

2023

Volltextzugriff (PDF)

Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer

Cancer chemotherapy and pharmacology, 2012-04, Vol.69 (4), p.1005-1011

2012

Volltextzugriff (PDF)

733 3D electron microscopy revealed that lamellar granules are secreted on the underside of more matured granular cells

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S126-S126

2023

Volltextzugriff (PDF)

760 Analysis of sphingosine 1-phosphate receptor 3-5 functions and distributions in the epidermis

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S131-S131

2023

Volltextzugriff (PDF)

836 Possibility of precision medicine based on functional analysis of keratin mutation in epidermolysis bullosa simplex

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S143-S143

2023

Volltextzugriff (PDF)

Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease

Clinical and experimental dermatology, 2009-12, Vol.34 (8), p.e1023-e1024

2009

Volltextzugriff (PDF)

363 Systemic sphingosine 1-phosphate receptor 2 (S1PR2) deficiency facilitates dermal neutrophil infiltration against S. aureus infection

Journal of investigative dermatology, 2020-07, Vol.140 (7), p.S45-S45

2020

Volltextzugriff (PDF)

(170) ACUTE STRESS DISORDER DURING LABOR IS A PREDICTOR OF POST-PARTUM DYSPAREUNIA

Journal of sexual medicine, 2023-07, Vol.20 (Supplement_4)

2023

Volltextzugriff (PDF)

Homoleptic Cyclometalated Iridium Complexes with Highly Efficient Red Phosphorescence and Application to Organic Light-Emitting Diode

Journal of the American Chemical Society, 2003-10, Vol.125 (42), p.12971-12979

2003

Volltextzugriff (PDF)

353 Sphingosine 1-phosphate receptor 2 (S1PR2) deficiency alters skin barrier homeostasis

Journal of investigative dermatology, 2019-05, Vol.139 (5), p.S61-S61

2019

Volltextzugriff (PDF)

Analysis of sleep environment in ICT users

Sleep medicine, 2017-12, Vol.40, p.e236-e237

2017

Volltextzugriff (PDF)

853 Dermal fibroblasts control mast cell reactivity to commensal bacteria

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S145-S145

2018

Volltextzugriff (PDF)

974 Sphingosine 1-phosphate receptor 1 and 2 control proinflammatory cytokine response to S. aureus in normal human keratinocytes

Journal of investigative dermatology, 2018-05, Vol.138 (5), p.S165-S165

2018

Volltextzugriff (PDF)

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder

Advances in Urology, 2011-01, Vol.2011, p.820816-8

2011

Volltextzugriff (PDF)

P2.04-87 Efficacy of Immune Checkpoint Inhibitors for Locally Advanced Non-Small Cell Lung Cancer Patients Before Durvalumab Approval

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S743-S744

2019

Volltextzugriff (PDF)

401P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of oncology, 2020-11, Vol.31, p.S1399-S1400

2020

Volltextzugriff (PDF)

1365P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of oncology, 2020-09, Vol.31, p.S872-S873

2020

Volltextzugriff (PDF)

Substituent effects of iridium complexes for highly efficient red OLEDs

Dalton transactions : an international journal of inorganic chemistry, 2005-01 (9), p.1583-1590

2005

Volltextzugriff (PDF)

P78.06 Dynamic Risk Prediction for Disease Control With Nivolumab in Advanced or Recurrent Non-Small Cell Lung Cancer Patients (NewEpoch)

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S640-S640

2021

Volltextzugriff (PDF)

P76.53 Impact of Neutrophil-to-Lymphocyte Ratio in Patients with EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibitors

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S610-S610

2021

Volltextzugriff (PDF)

P76.55 Real-world Experience of the Utility in Afatinib Therapy for Patients with EGFR-Mutant Advanced NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S611-S611

2021

Volltextzugriff (PDF)

P1.14-36 Phase II Trial of Afatinib in Elderly Patients Aged Over 75 Years with EGFR Mutation Positive Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S568-S568

2019

Volltextzugriff (PDF)

EP1.01-68 Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S938-S938

2019

Volltextzugriff (PDF)

1 – 25 von 3.729

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.668)
Mit Volltextzugriff
(3.295)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.700)
Life Sciences & Biomedicine
(1.291)
Humans
(977)
Male
(735)
Female
(566)
Middle Aged
(434)
Aged
(424)
Biological And Medical Sciences
(399)
Animals
(377)
Medical Sciences
(344)
Adult
(304)
Physical Sciences
(302)
Urology & Nephrology
(237)
Chemistry
(209)
Technology
(194)
Oncology
(188)
Urology
(175)
Aged, 80 And Over
(171)
Rats
(160)
Cardiovascular System & Cardiology
(144)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Promising Response to Dabrafenib Plus Trametinib in a Patient with Peritoneal Carcinomatosis from Non Small Lung Cancer Harboring BRAF V600E Mutation

Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018

703 S. epidermidis increases contact sensitization inflammation through the S1P receptor 2

Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer

733 3D electron microscopy revealed that lamellar granules are secreted on the underside of more matured granular cells

760 Analysis of sphingosine 1-phosphate receptor 3-5 functions and distributions in the epidermis

836 Possibility of precision medicine based on functional analysis of keratin mutation in epidermolysis bullosa simplex

Childhood generalized pustular psoriasis treated by preprandial ciclosporin administration: serum cytokine pattern during the course of the disease

363 Systemic sphingosine 1-phosphate receptor 2 (S1PR2) deficiency facilitates dermal neutrophil infiltration against S. aureus infection

(170) ACUTE STRESS DISORDER DURING LABOR IS A PREDICTOR OF POST-PARTUM DYSPAREUNIA

Homoleptic Cyclometalated Iridium Complexes with Highly Efficient Red Phosphorescence and Application to Organic Light-Emitting Diode

353 Sphingosine 1-phosphate receptor 2 (S1PR2) deficiency alters skin barrier homeostasis

Analysis of sleep environment in ICT users

853 Dermal fibroblasts control mast cell reactivity to commensal bacteria

974 Sphingosine 1-phosphate receptor 1 and 2 control proinflammatory cytokine response to S. aureus in normal human keratinocytes

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder

P2.04-87 Efficacy of Immune Checkpoint Inhibitors for Locally Advanced Non-Small Cell Lung Cancer Patients Before Durvalumab Approval

401P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

1365P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Substituent effects of iridium complexes for highly efficient red OLEDs

P78.06 Dynamic Risk Prediction for Disease Control With Nivolumab in Advanced or Recurrent Non-Small Cell Lung Cancer Patients (NewEpoch)

P76.53 Impact of Neutrophil-to-Lymphocyte Ratio in Patients with EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibitors

P76.55 Real-world Experience of the Utility in Afatinib Therapy for Patients with EGFR-Mutant Advanced NSCLC

P1.14-36 Phase II Trial of Afatinib in Elderly Patients Aged Over 75 Years with EGFR Mutation Positive Non-Small Cell Lung Cancer

EP1.01-68 Impact of EGFR Genotype on the Efficacy of Osimertinib in Patients with Non-Small Cell Lung Cancer: A Prospective Observational Study

Suchergebnisse filtern